First Time Loading...
I

InBody Co Ltd
KOSDAQ:041830

Watchlist Manager
InBody Co Ltd
KOSDAQ:041830
Watchlist
Price: 26 850 KRW -0.19% Market Closed
Updated: May 21, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
InBody Co Ltd

Revenue
170.4B KRW
Cost of Revenue
-37.9B KRW
Gross Profit
132.5B KRW
Operating Expenses
-94.1B KRW
Operating Income
38.3B KRW
Other Expenses
-1.6B KRW
Net Income
36.7B KRW

Margins Comparison
InBody Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
InBody Co Ltd
KOSDAQ:041830
349.8B KRW
78%
23%
22%
US
Abbott Laboratories
NYSE:ABT
179.5B USD
55%
16%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.9B USD
66%
25%
27%
US
Stryker Corp
NYSE:SYK
125.6B USD
64%
21%
16%
IE
Medtronic PLC
NYSE:MDT
112.4B USD
66%
20%
13%
US
Boston Scientific Corp
NYSE:BSX
110.8B USD
69%
17%
12%
US
Becton Dickinson and Co
NYSE:BDX
68.9B USD
41%
11%
7%
DE
Siemens Healthineers AG
XETRA:SHL
59B EUR
38%
12%
8%
US
Edwards Lifesciences Corp
NYSE:EW
54B USD
77%
29%
23%
US
Dexcom Inc
NASDAQ:DXCM
51.8B USD
63%
17%
17%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
369.6B CNY
65%
35%
34%
Country KR
Market Cap 349.8B KRW
Gross Margin
78%
Operating Margin
23%
Net Margin
22%
Country US
Market Cap 179.5B USD
Gross Margin
55%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 141.9B USD
Gross Margin
66%
Operating Margin
25%
Net Margin
27%
Country US
Market Cap 125.6B USD
Gross Margin
64%
Operating Margin
21%
Net Margin
16%
Country IE
Market Cap 112.4B USD
Gross Margin
66%
Operating Margin
20%
Net Margin
13%
Country US
Market Cap 110.8B USD
Gross Margin
69%
Operating Margin
17%
Net Margin
12%
Country US
Market Cap 68.9B USD
Gross Margin
41%
Operating Margin
11%
Net Margin
7%
Country DE
Market Cap 59B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country US
Market Cap 54B USD
Gross Margin
77%
Operating Margin
29%
Net Margin
23%
Country US
Market Cap 51.8B USD
Gross Margin
63%
Operating Margin
17%
Net Margin
17%
Country CN
Market Cap 369.6B CNY
Gross Margin
65%
Operating Margin
35%
Net Margin
34%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
InBody Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
InBody Co Ltd
KOSDAQ:041830
349.8B KRW
16%
14%
16%
19%
US
Abbott Laboratories
NYSE:ABT
179.5B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
141.9B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
125.6B USD
19%
9%
14%
11%
IE
Medtronic PLC
NYSE:MDT
112.4B USD
8%
5%
8%
6%
US
Boston Scientific Corp
NYSE:BSX
110.8B USD
9%
5%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
68.9B USD
5%
2%
5%
4%
DE
Siemens Healthineers AG
XETRA:SHL
59B EUR
10%
4%
8%
5%
US
Edwards Lifesciences Corp
NYSE:EW
54B USD
22%
15%
22%
22%
US
Dexcom Inc
NASDAQ:DXCM
51.8B USD
29%
11%
15%
18%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
369.6B CNY
36%
25%
34%
46%
Country KR
Market Cap 349.8B KRW
ROE
16%
ROA
14%
ROCE
16%
ROIC
19%
Country US
Market Cap 179.5B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 141.9B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 125.6B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country IE
Market Cap 112.4B USD
ROE
8%
ROA
5%
ROCE
8%
ROIC
6%
Country US
Market Cap 110.8B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
6%
Country US
Market Cap 68.9B USD
ROE
5%
ROA
2%
ROCE
5%
ROIC
4%
Country DE
Market Cap 59B EUR
ROE
10%
ROA
4%
ROCE
8%
ROIC
5%
Country US
Market Cap 54B USD
ROE
22%
ROA
15%
ROCE
22%
ROIC
22%
Country US
Market Cap 51.8B USD
ROE
29%
ROA
11%
ROCE
15%
ROIC
18%
Country CN
Market Cap 369.6B CNY
ROE
36%
ROA
25%
ROCE
34%
ROIC
46%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More